EUVIMEDEUVIMED entdecken
VergleichsstudieValidierungsstudie

Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA

Rajan Rehan iD, Chinmay Khandur iD, Christopher C Y Wong iD, James Weaver iD, Pankaj Jain, Mark Adams, Martin K C Ng, Jennifer A Tremmel iD, Andy S C Yong iD

Circulation: Cardiovascular Interventions · 2025

DOI: 10.1161/circinterventions.125.015339 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Rajan Rehan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia (R.R., C.K., J.W., P.J., M.A., M.K.C.N.). Hauptthemen laut MEDLINE: Acetylcholine, Coronary Vasospasm, Coronary Vessels, Angina Pectoris. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronary artery spasm (CAS) is a common cause of angina with nonobstructive coronary arteries (ANOCA). While acetylcholine provocation testing is the diagnostic gold standard, protocol variations have led to discrepancies in diagnostic accuracy. This study aimed to compare the diagnostic validity of conventional versus high-dose acetylcholine regimens in patients with ANOCA. METHODS: Multivessel acetylcholine provocation testing was systematically performed in patients with ANOCA and a control cohort undergoing invasive coronary angiography for noncoronary indications. Incremental acetylcholine doses in the left (20–200 μg) and right (20–80 μg) coronary arteries were manually injected over 20 seconds to induce CAS. RESULTS: The study included 62 patients with ANOCA with typical CAS symptoms and 20 controls. Conventional-dose acetylcholine testing identified CAS in 67.1% (55/82) of patients, while high-dose testing detected CAS in 79.3% (65/82). Among patients with inducible spasm, 93.4% (61/65) had typical angina consistent with CAS. High-dose acetylcholine demonstrated significantly higher sensitivity (98% versus 87%, P =0.008), but a nonsignificant trend toward lower specificity (80% versus 95%, P =0.08). The high-dose regimen also showed a higher negative predictive value (94% versus 70%, P =0.01), while positive predictive values were comparable (93% versus 98%, P =0.12). CONCLUSIONS: High-dose acetylcholine provocation improves the detection of CAS in patients with ANOCA but may increase the risk of overdiagnosis. This approach should be reserved for patients with a high clinical suspicion of CAS, with the results interpreted within the broader clinical context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcholineCoronary VasospasmCoronary VesselsAngina PectorisVasoconstrictionVasodilator AgentsHumansMaleFemaleMiddle AgedPredictive Value of TestsCoronary AngiographyAgedReproducibility of ResultsCase-Control Studies

Stichwörter der Autor:innen

acetylcholinecoronary angiographycoronary vasospasmhumansoverdiagnosis

Substanzen

AcetylcholineVasodilator Agents

Autor:innen und Institutionen

  • Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia (R.R., C.K., J.W., P.J., M.A., M.K.C.N.).
  • Department of Cardiology, Concord Hospital, Sydney, New South Wales, Australia (R.R., C.K., A.S.C.Y.).
  • Sydney Medical School, University of Sydney, New South Wales, Australia (R.R., C.K., J.W., P.J., M.A., M.K.C.N., A.S.C.Y.).
  • Division of Cardiovascular Medicine, Stanford University School of Medicine and Stanford Cardiovascular Institute, CA (C.C.Y.W., J.A.T.).
  • Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia (M.K.C.N., A.S.C.Y.).

ORCID-Profile: Rajan Rehan, Chinmay Khandur, Christopher C Y Wong, James Weaver, Jennifer A Tremmel, Andy S C Yong

Zitieren

APA

Rehan, R., Khandur, C., Wong, C. C. Y., Weaver, J., Jain, P., Adams, M., Ng, M. K. C., Tremmel, J. A., & Yong, A. S. C. (2025). Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015339

Vancouver

Rehan R, Khandur C, Wong CCY, Weaver J, Jain P, Adams M, et al. Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.125.015339

BibTeX
@article{Rehan2025,
  author = {Rehan, Rajan and Khandur, Chinmay and Wong, Christopher C Y and Weaver, James and Jain, Pankaj and Adams, Mark and Ng, Martin K C and Tremmel, Jennifer A and Yong, Andy S C},
  title = {Diagnostic Validity of Acetylcholine Provocation Protocols in the Evaluation of Coronary Artery Spasm in Patients With ANOCA},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1161/circinterventions.125.015339}
}
Kostenlos starten →